The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 69-78 , January 2010

Advances in pediatric asthma in 2009: Gaining control of childhood asthma

  • Stanley J. Szefler, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Stanley J. Szefler, MD, National Jewish Health, 1400 Jackson St, Rm J304, Molly Blank Building, Denver, CO 80206.

Received 4 November 2009 ,Accepted 4 November 2009.

References 

  1. Szefler SJ. Advances in pediatric asthma in 2008: where do we go now?. J Allergy Clin Immunol. 2009;123:28–34
  2. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda: National Institutes of Health; 2007;NIH publication no. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm
  3. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol. 2007;120(suppl):S94–S138
  4. Haselkorn T, Fish JE, Zeiger RS, Szefler SJ, Miller DP, Chipps BE, et al. Consistently very poorly controlled asthma by the impairment domain of the EPR-3 guidelines increases risk for future severe asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens study. J Allergy Clin Immunol. 2009;124:895–902
  5. Haselkorn T, Zeiger RS, Chipps BE, Mink DR, Szefler SJ, Simons ER, et al. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124:921–927
  6. Bryant-Stephens T. Asthma disparities in urban environments. J Allergy Clin Immunol. 2009;123:1199–1206
  7. Canino G, McQuaid EL, Rand CS. Addressing asthma health disparities: a multilevel challenge. J Allergy Clin Immunol. 2009;123:1209–1217
  8. Valet RS, Perry TT, Hartert TV. Rural health disparities in asthma care and outcomes. J Allergy Clin Immunol. 2009;123:1220–1225
  9. Apter AJ, Casillas AM. Eliminating health disparities: what have we done and what do we do next?. J Allergy Clin Immunol. 2009;123:1237–1239
  10. Gruchalla RS, Sampson HA, Matsui E, David G, Gergen PJ, Calatronia A, et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol. 2009;124:213–221
  11. Naimi DR, Freedman TG, Ginsburg KR, Bogen D, Rand CS, Apter AJ. Adolescents and asthma: why bother with our meds?. J Allergy Clin Immunol. 2009;123:1335–1341
  12. Esteban CA, Klein RB, McQuaid EL, Fritz GK, Seifer R, Kopel SJ, et al. Conundrums in childhood asthma severity, control and health care use: Puerto Rico versus Rhode Island. J Allergy Clin Immunol. 2009;124:238–244
  13. Gupta RS, Zhang X, Sharp LK, Shannon JJ, Weiss KB. The protective effect of community factors on childhood asthma. J Allergy Clin Immunol. 2009;123:1297–1304
  14. Szefler SJ. Managing asthma and allergies in schools: an opportunity to coordinate health care. J Allergy Clin Immunol. 2009;124:201–204
  15. Kruzick T, Covar RA, Gleason M, Cicutto L, White M, Shocks D, et al. Does access to asthma care equal control in school-aged children?. J Allergy Clin Immunol. 2009;124:381–382
  16. Bruzzese JM, Evans D, Kattan M. School-based asthma programs. J Allergy Clin Immunol. 2009;124:195–200
  17. Cicutto L. Supporting successful asthma management in schools: the role of asthma care providers. J Allergy Clin Immunol. 2009;124:390–393
  18. Salo PM, Sever ML, Zeldin DC. Indoor allergens in school and day care environments. J Allergy Clin Immunol. 2009;124:185–192
  19. Schatz M, Kazzi AAN, Brenner B, Camargo CA, Cobridge T, Krishnan JA, et al. Introduction. J Allergy Clin Immunol. 2009;124(suppl):S1–S4
  20. Camargo CA, Rachelefsky G, Schatz M. Managing asthma exacerbations in the emergency department: summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations. J Allergy Clin Immunol. 2009;124(suppl):S5–S14
  21. Ducharme FM, Lemire C, Noya FJD, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360:339–353
  22. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009;360:329–338
  23. Bush A. Practice Imperfect—treatment for wheezing in preschoolers. N Engl J Med. 2009;360:409–420
  24. Kelly HW. What is the dose of systemic corticosteroids for severe asthma exacerbations in children?. Pediatr Asthma Allergy Immunol. 2009;22:75–79
  25. Philip G, Hustad CM, Noonan G, Malice MP, Ezekowitz A, Phil D, et al. Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124:691–696
  26. Philip G, Hustad CM, Malice MP, Noonan G, Ezekowitz A, Reiss TF, et al. Analysis of behavior-related adverse experiences in clinical trials of montelukast. J Allergy Clin Immunol. 2009;124:699–706
  27. Kelsay K. Assessing risk: Data from montelukast clinical trials. J Allergy Clin Imunol. 2009;124:697–698
  28. Suttner K, Ruoss I, Rosenstiel P, Depner M, Pinto LA, Schedel M, et al. HLX1 gene variants influence the development of childhood asthma. J Allergy Clin Immunol. 2009;123:82–88
  29. Suttner K, Rosenstiel P, Depner M, Schedel M, Pinto LA, Ruether A, et al. TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol. 2009;123:1062–1068
  30. Suttner K, Depner M, Klopp N, Illig T, Vogelberg C, Adamski J, et al. Genetic variants in the GATA3 gene are not associated with asthma and atopic diseases in German children. J Allergy Clin Immunol. 2009;123:1179–1181
  31. Bisgaard H, Loland L, Holst KK, Pipper CB. Prenatal determinants of neonatal lung function in high-risk newborns. J Allergy Clin Immunol. 2009;123:651–657
  32. Yemen S, Gaston B. Lung function test results in normal infants: a COPSAC sequel. J Allergy Clin Immunol. 2009;123:658–659
  33. Cookson H, Granell R, Joinson C, Ben-Shlomo Y, Henderson AJ. Mothers' anxiety during pregnancy is associated with asthma in their children. J Allergy Clin Immunol. 2009;123:847–853
  34. Keski-Nisula L, Katila ML, Remes S, Heinone S, Pekkanen J. Intrauterine bacterial growth at birth and risk of asthma and allergic sensitization among offspring at the age of 15 to 17 years. J Allergy Clin Immunol. 2009;123:1305–1311
  35. Upham JW, Zhang G, Rate A, Yerkovich ST, Kusel M, Sly PD, et al. Plasmacytoid dendritic cells during infancy are inversely associated with childhood respiratory infections and wheezing. J Allergy Clin Immunol. 2009;124:707–713
  36. Gergen PJ, Arbes SJ, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2009;124:447–453
  37. Farquhar H, Crane J, Mitchell EA, Eyers S, Beasley R. The acetaminophen and asthma hypothesis ten years on: a case to answer. J Allergy Clin Immunol. 2009;124:649–651
  38. Foliaki S, Pearce N, Bjorkstein B, Mallol J, Montefort S, von Mutius E, et al. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in 6-7 year olds: ISAAC phase three. J Allergy Clin Immunol. 2009;124:982–990
  39. Carroll KN, Wu P, Gebretsadik T, Griffin MR, Dupont WD, Mitchel EF, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol. 2009;123:1055–1061
  40. Caudri D, Wijga A, Schipper MA, Hoekstra M, Postma D, Koppelman G, et al. Predicting the long term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol. 2009;124:903–910
  41. Pali-Scholl I, Renz H, Jensen-Jarolim E. Update on allergies in pregnancy, lactation and early childhood. J Allergy Clin Immunol. 2009;123:1012–1021
  42. Murphy KR, Zeiger RS, Kosinski M, Chipps B, Mellon M, Schatz M, et al. Test for respiratory and asthma control in kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol. 2009;123:833–839
  43. Larsen GL, Morgan W, Heldt GP, Mauger DT, Boehmer SJ, Chinchilli VM, et al. Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol. 2009;123:861–867
  44. Wu AC, Tantisira K, Li L, Schuemann B, Weiss S for the Childhood Asthma Management Program Research Group. Repeatability of response to asthma medications. J Allergy Clin Immunol. 2009;123:385–390
  45. Bacharier LB, Guilbert TW, Zeiger RS, Strunk RC, Morgan WJ, Lemanske RF, et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol. 2009;123:1077–1082
  46. Knuffman JE, Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Martinez FD, et al. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. 2009;123:411–416
  47. Lee TH. Woszczek G, Farooque SP. Leukotriene E4: Perspective on the forgotten mediator. J Allergy Clin Immunol. 2009;124:417–421
  48. Tantisira KG, Drazen JM. Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol. 2009;124:422–427
  49. O'Byrne PM, Gauvreau GM, Murphy DM. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma. J Allergy Clin Immunol. 2009;124:397–403
  50. Coogan PF, Palmer JR, O'Connor GT, Rosenberg L. Body mass index and asthma incidence in the Black Women's Health Study. J Allergy Clin Immunol. 2009;123:89–95
  51. Clerisme-Beaty E, Rand CS. The effect of obesity on asthma incidence: moving past the epidemiologic evidence. J Allergy Clin Immunol. 2009;123:96–97
  52. Scholtens S, Wijga AH, Seidell JC, Brunekreef B, deJongste JC, Gehring U, et al. Overweight and changes in weight status during childhood in relation to asthma symptoms at 8 years of age. J Allergy Clin Immunol. 2009;123:1312–1318
  53. Schwartzstein RM, Gold DR. Dyspnea in overweight children: is it asthma?. J Allergy Clin Immunol. 2009;123:1319–1320
  54. Musaad SMA, Patterson T, Ericksen M, Lindsey M, Dietrich K, Succop P, et al. Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant. J Allergy Clin Immunol. 2009;123:1321–1327
  55. Stensballe LG, Simonsen JB, Thomsen SF, Larsen AMH, Lysdal SH, Aaby P, et al. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J Allergy Clin Immunol. 2009;123:131–137
  56. Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, et al. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol. 2009;123:398–403
  57. Glezen WP. Respiratory syncytial virus: back to basics. J Allergy Clin Immunol. 2009;123:404–405
  58. Juntti H, Osterlund P, Kokkonen J, Dunder T, Renko M, Pokka T, et al. Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection. J Allergy Clin Immunol. 2009;124:52–58
  59. Dakhama A, Lee YM, Ohnishi H, Jing X, Balhorn A, Takeda K, et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol. 2009;123:138–145
  60. Miller EK, Edwards KM, Weinberg GA, Iwane MK, Griffin MR, Hall CB, et al. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009;123:98–104
  61. Gern JE, Busse WW. Learning from molecular sleuths. J Allergy Clin Immunol. 2009;123:105–106
  62. Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikstrom ME, et al. interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol. 2009;183:2793–2800
  63. Khan FI, Reddy RC, Baptist AP. Pediatric dyspnea scale for use in hospitalized patients with asthma. J Allergy Clin Immunol. 2009;123:660–664
  64. Spahn JD, Sheth K, Yeh W-S, Stempel DA, Stanford RH. Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall. J Allergy Clin Immunol. 2009;124:1197–1203
  65. Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol. 2009;124:1210–1216
  66. Basu K, Palmer CAN, Tavendale R, Lipworth BJ, Mukhopadhyay S. Adrenergic β2-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol. J Allergy Clin Immunol. 2009;124:1188–1194
  67. Zeiger RS, Chipps BE, Haselkorn T, Rasouliyan L, Simons ER, Fish JE. Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124:1106–1108
  68. Su RC, Becker AB, Kozyrskyj AL, HayGlass KT. Altered epigenetic regulation and increasing severity of bronchial hyper-responsiveness in atopic asthmatic children. J Allergy Clin Immunol. 2009;124:1116–1118
  69. Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LAS for the Severe Asthma Research Program. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol. 2009;123:146–152
  70. Dolhnikoff M, da Silva LFF, de Araujo BB, Gomez HAP, Fernezlian S, Mulder A, et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol. 2009;123:1090–1097
  71. Barton SJ, Koppelman GH, Vonk JM, Browning CA, Nolte IM, Stewart CE, et al. PLAUR polymorphisms are associated with asthma, PLAUR levels and lung function decline. J Allergy Clin Immunol. 2009;123:1391–1400
  72. Enomoto Y, Orihara K, Takamasu T, Matsuda A, Gon Y, Saito H, et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway following an acute asthma attack. J Allergy Clin Immunol. 2009;124:913–920
  73. Salam MT, Islam T, Gauderman J, Gilliland FD. Roles of arginase variants, atopy, and ozone in childhood asthma. J Allergy Clin Immunol. 2009;123:596–602
  74. Wichmann FA, Muller A, Busi LE, Cianni N, Massolo L, Schlink U, et al. Increased asthma and respiratory symptoms in children exposed to petrochemical pollution. J Allergy Clin Immunol. 2009;123:632–638
  75. Ronmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundback B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol. 2009;124:357–363
  76. Traidl-Hoffman C, Jakob T, Behrendt H. Determinants of allergenicity. J Allergy Clin Immunol. 2009;123:558–566
  77. Schaub B, Liu J, Hoppler S, Schleich I, Huehn J, Olek S, et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol. 2009;123:774–782
  78. Miller GE, Gaudin A, Zysk E, Chen E. Parental support and cytokine activity in childhood asthma: the role of glucocorticoid sensitivity. J Allergy Clin Immunol. 2009;123:824–830
  79. Wright RJ. Stress and acquired glucocorticoid resistance: a relationship hanging in the balance. J Allergy Clin Immunol. 2009;123:531–532
  80. Miller BD, Wood BL, Lim JH, Ballow M, Hsu CY. Depressed children with asthma evidence increased airway resistance: “vagal bias” as a mechanism?. J Allergy Clin Immunol. 2009;124:66–73
  81. Smith AD, Cowan JA, Taylor DR. Exhaled nitric oxide levels in asthma: “personal best” versus reference values. J Allergy Clin Immunol. 2009;124:714–718
  82. Jackson DJ, Virnig CM, Gangnon RE, Evans MD, Roberg KA, Anderson EL, et al. Fractional exhaled nitric oxide (FeNO) measurements are most closely associated with allergic sensitization in school aged children. J Allergy Clin Immunol. 2009;124:949–953
  83. Fitzpatrick AM, Brown LAS, Holguin F, Teague WG for the NIH/NHLBI Severe Asthma Research Program. Nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. J Allergy Clin Immunol. 2009;124:990–996
  84. Hollams EM, Deverell M, Serralha M, Suriyaarachchi D, Parsons F, Zhang G, et al. Elucidation of asthma phenotypes in atopic teenagers through parallel immunophenotypic and clinical profiling. J Allergy Clin Immunol. 2009;124:463–470
  85. He JQ, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, et al. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol. 2009;124:222–229
  86. Von Mutius E. Gene-environment interactions in asthma. J Allergy Clin Immunol. 2009;123:3–11
  87. Vercelli D. Gene-environment interactions: the road less traveled by in asthma genetics. J Allergy Clin Immunol. 2009;123:26–27
  88. Flory JH, Sleiman PM, Christie JD, Annaiah K, Bradfield J, Kim CE, et al. 17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry. J Allergy Clin Immunol. 2009;124:605–607
  89. Marenholz I, Kerscher T, Bauerfeind A, Esparza-Gordillo J, Nickel R, Keil T, et al. An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma. J Allergy Clin Immunol. 2009;123:911–916

 Supported in part by Public Health Services research grants HR-16048, HL64288, HL 51834, AI-25496, HL081335, and HL075416 and the Colorado Cancer, Cardiovascular, and Pulmonary Disease Program. Supported in part by Colorado CTSA grant 1 UL1 RR025780 from the National Institutes of Health and the National Center for Research Resources.

 Disclosure of potential conflict of interest: S. J. Szefler has consulted for GlaxoSmithKline, Genentech, Merck, and Boehringer-Ingelheim and has received research support from the National Institutes of Health; the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; and GlaxoSmithKline.

PII: S0091-6749(09)01720-5

doi: 10.1016/j.jaci.2009.11.006

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 1 , Pages 69-78 , January 2010

Article Tools